Durvalumab (Imfinzi)
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for Durvalumab (Imfinzi), covering 2019-11-29 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure [Phase 2]